Cargando…

The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects

Detalles Bibliográficos
Autores principales: Vicenti, Ilaria, Gatti, Francesca, Scaggiante, Renzo, Boccuto, Adele, Zago, Daniela, Basso, Monica, Dragoni, Filippo, Parisi, Saverio Giuseppe, Zazzi, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329626/
https://www.ncbi.nlm.nih.gov/pubmed/34342854
http://dx.doi.org/10.1007/s15010-021-01680-z
_version_ 1783732549184389120
author Vicenti, Ilaria
Gatti, Francesca
Scaggiante, Renzo
Boccuto, Adele
Zago, Daniela
Basso, Monica
Dragoni, Filippo
Parisi, Saverio Giuseppe
Zazzi, Maurizio
author_facet Vicenti, Ilaria
Gatti, Francesca
Scaggiante, Renzo
Boccuto, Adele
Zago, Daniela
Basso, Monica
Dragoni, Filippo
Parisi, Saverio Giuseppe
Zazzi, Maurizio
author_sort Vicenti, Ilaria
collection PubMed
description
format Online
Article
Text
id pubmed-8329626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83296262021-08-03 The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects Vicenti, Ilaria Gatti, Francesca Scaggiante, Renzo Boccuto, Adele Zago, Daniela Basso, Monica Dragoni, Filippo Parisi, Saverio Giuseppe Zazzi, Maurizio Infection Correspondence Springer Berlin Heidelberg 2021-08-03 2022 /pmc/articles/PMC8329626/ /pubmed/34342854 http://dx.doi.org/10.1007/s15010-021-01680-z Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Vicenti, Ilaria
Gatti, Francesca
Scaggiante, Renzo
Boccuto, Adele
Zago, Daniela
Basso, Monica
Dragoni, Filippo
Parisi, Saverio Giuseppe
Zazzi, Maurizio
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
title The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
title_full The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
title_fullStr The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
title_full_unstemmed The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
title_short The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
title_sort second dose of the bnt162b2 mrna vaccine does not boost sars-cov-2 neutralizing antibody response in previously infected subjects
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329626/
https://www.ncbi.nlm.nih.gov/pubmed/34342854
http://dx.doi.org/10.1007/s15010-021-01680-z
work_keys_str_mv AT vicentiilaria theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT gattifrancesca theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT scaggianterenzo theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT boccutoadele theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT zagodaniela theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT bassomonica theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT dragonifilippo theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT parisisaveriogiuseppe theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT zazzimaurizio theseconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT vicentiilaria seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT gattifrancesca seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT scaggianterenzo seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT boccutoadele seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT zagodaniela seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT bassomonica seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT dragonifilippo seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT parisisaveriogiuseppe seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects
AT zazzimaurizio seconddoseofthebnt162b2mrnavaccinedoesnotboostsarscov2neutralizingantibodyresponseinpreviouslyinfectedsubjects